Hope Cancer Center
Terre Haute, Indiana, United States
Cancer treatment center in Terre Haute, Indiana
3702 S 4th St, Terre Haute, IN 47802
About Hope Cancer Center
"Hope Center for Blood Disease and Cancer Care, providing cancer and blood disease care"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
SCRI Development Innovations, LLC
4
Northwestern University
1
Clinical Trials at Hope Cancer Center
During the past decade, Hope Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer
2010-01-18
2015-01-01
Completed
28
FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only
2010-12-01
2014-03-01
Completed
15
A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
2012-01-01
2015-07-01
Completed
70
Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
2014-03-01
2021-05-01
Completed
71
Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer
2014-12-18
2019-01-31
Completed
48
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hope Cancer Center"
#1 collaborator was "Amgen" with 2 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator and "OSI Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Hope Cancer Center
According to Clinical.Site data, the most researched conditions in "Hope Cancer Center" are
"Colorectal Cancer" (3 trials), "Breast Cancer" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Hope Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at Hope Cancer Center
Most popular intervention types in "Hope Cancer Center" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "5-Fluorouracil" (2 trials), "Leucovorin" (2 trials), "Oxaliplatin" (2 trials), "Anastrozole" (1 trials) and "Axitinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hope Cancer Center
The vast majority of trials in "Hope Cancer Center" are
4 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Hope Cancer Center
Currently, there are NaN active trials in "Hope Cancer Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Hope Cancer Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hope Cancer Center, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".